These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 7692677

  • 1. [Guidelines for drug treatment of multiple sclerosis].
    Kollegger H, Vass K, Marschall I, Koch G, Deecke L.
    Wien Klin Wochenschr; 1993; 105(16):443-52. PubMed ID: 7692677
    [Abstract] [Full Text] [Related]

  • 2. [Immunomodulatory therapy in multiple sclerosis].
    Csépány T, Bereczki D.
    Ideggyogy Sz; 2004 Nov 20; 57(11-12):401-16. PubMed ID: 15662768
    [Abstract] [Full Text] [Related]

  • 3. [Long-term effects of glatiramer acetate in multiple sclerosis].
    Brochet B.
    Rev Neurol (Paris); 2008 Nov 20; 164(11):917-26. PubMed ID: 18790510
    [Abstract] [Full Text] [Related]

  • 4. Natural history and treatment of multiple sclerosis.
    Weinshenker BG, Sibley WA.
    Curr Opin Neurol Neurosurg; 1992 Apr 20; 5(2):203-11. PubMed ID: 1377973
    [Abstract] [Full Text] [Related]

  • 5. Management of worsening multiple sclerosis with mitoxantrone: a review.
    Fox EJ.
    Clin Ther; 2006 Apr 20; 28(4):461-74. PubMed ID: 16750460
    [Abstract] [Full Text] [Related]

  • 6. [New therapeutic possibilities for disseminated sclerosis?].
    Wanscher B, Sørensen PS.
    Ugeskr Laeger; 1994 Oct 24; 156(43):6353-8. PubMed ID: 7810008
    [Abstract] [Full Text] [Related]

  • 7. [Treatment of multiple sclerosis. The present and the future. Study Group on Diagnosis and Therapy of Multiple Sclerosis].
    Cazzato G, Antonello RM, Zorzon M, Torre P, Zivadinov R, Moretti R, Bragadin LM, De Masi R, Nasuelli D.
    Recenti Prog Med; 1999 Oct 24; 90(10):538-44. PubMed ID: 10592740
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Multiple sclerosis: clinical presentation, diagnosis and treatment.
    Brod SA, Lindsey JW, Wolinsky JS.
    Am Fam Physician; 1996 Sep 15; 54(4):1301-6, 1309-11. PubMed ID: 8816574
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Treatment of progressive forms of multiple sclerosis].
    Edan G.
    Rev Neurol (Paris); 2001 Sep 15; 157(8-9 Pt 2):1008-13. PubMed ID: 11787331
    [Abstract] [Full Text] [Related]

  • 15. [Multiple sclerosis--current status of therapy].
    Reichel D, Kölmel HW.
    Z Arztl Fortbild (Jena); 1995 May 15; 89(2):151-8. PubMed ID: 7610682
    [Abstract] [Full Text] [Related]

  • 16. [Oral, low-dosage methotrexate in chronic progressive multiple sclerosis. A preliminary critical analysis].
    Weilbach FX, Toyka KV, Hartung HP.
    Nervenarzt; 1995 Aug 15; 66(8):643-7. PubMed ID: 7566279
    [No Abstract] [Full Text] [Related]

  • 17. Current disease-modifying therapies in multiple sclerosis.
    Kieseier BC, Hartung HP.
    Semin Neurol; 2003 Jun 15; 23(2):133-46. PubMed ID: 12894379
    [Abstract] [Full Text] [Related]

  • 18. Azathioprine and methotrexate in multiple sclerosis.
    Fernández O, Fernández V, De Ramón E.
    J Neurol Sci; 2004 Aug 15; 223(1):29-34. PubMed ID: 15261557
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Treatment of remitting forms of multiple sclerosis].
    Lubetzki C.
    Rev Neurol (Paris); 2001 Sep 15; 157(8-9 Pt 2):996-1000. PubMed ID: 11787366
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.